Correlation Between Seres Therapeutics and Madrigal Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Seres Therapeutics and Madrigal Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Seres Therapeutics and Madrigal Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Seres Therapeutics and Madrigal Pharmaceuticals, you can compare the effects of market volatilities on Seres Therapeutics and Madrigal Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Seres Therapeutics with a short position of Madrigal Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Seres Therapeutics and Madrigal Pharmaceuticals.
Diversification Opportunities for Seres Therapeutics and Madrigal Pharmaceuticals
-0.29 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Seres and Madrigal is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Seres Therapeutics and Madrigal Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Madrigal Pharmaceuticals and Seres Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Seres Therapeutics are associated (or correlated) with Madrigal Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Madrigal Pharmaceuticals has no effect on the direction of Seres Therapeutics i.e., Seres Therapeutics and Madrigal Pharmaceuticals go up and down completely randomly.
Pair Corralation between Seres Therapeutics and Madrigal Pharmaceuticals
Given the investment horizon of 90 days Seres Therapeutics is expected to generate 3.39 times less return on investment than Madrigal Pharmaceuticals. In addition to that, Seres Therapeutics is 1.43 times more volatile than Madrigal Pharmaceuticals. It trades about 0.02 of its total potential returns per unit of risk. Madrigal Pharmaceuticals is currently generating about 0.12 per unit of volatility. If you would invest 23,476 in Madrigal Pharmaceuticals on September 12, 2024 and sell it today you would earn a total of 7,801 from holding Madrigal Pharmaceuticals or generate 33.23% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Seres Therapeutics vs. Madrigal Pharmaceuticals
Performance |
Timeline |
Seres Therapeutics |
Madrigal Pharmaceuticals |
Seres Therapeutics and Madrigal Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Seres Therapeutics and Madrigal Pharmaceuticals
The main advantage of trading using opposite Seres Therapeutics and Madrigal Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Seres Therapeutics position performs unexpectedly, Madrigal Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Madrigal Pharmaceuticals will offset losses from the drop in Madrigal Pharmaceuticals' long position.Seres Therapeutics vs. Syros Pharmaceuticals | Seres Therapeutics vs. Iovance Biotherapeutics | Seres Therapeutics vs. Veracyte | Seres Therapeutics vs. Fate Therapeutics |
Madrigal Pharmaceuticals vs. TG Therapeutics | Madrigal Pharmaceuticals vs. Terns Pharmaceuticals | Madrigal Pharmaceuticals vs. Hepion Pharmaceuticals | Madrigal Pharmaceuticals vs. Viking Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |